Increased expression of MET contributes to cancer cell proliferation, invasion, and metastasis and is closely correlated with poor prognosis and radiotherapy resistance, which has been a prognostic biomarker and therapeutic target for various carcinomas [25]. Here, MET is linked to cancer.